A Comment on the Post-Finasteride Syndrome.

Area of Science:

• Dermatology
• Endocrinology
• Pharmacology

Background:

• Post-Finasteride Syndrome (PFS) is a controversial condition claimed to cause persistent sexual, mental, and physical side effects after oral finasteride use for hair loss or BPH.
• The incidence and scientific recognition of PFS remain unknown, with existing research often criticized for low quality, bias, and potential nocebo effects.

Purpose of the Study:

• To address the complexities surrounding Post-Finasteride Syndrome (PFS).
• To provide practical recommendations for managing potential adverse events associated with finasteride.
• To discuss alternatives to oral finasteride, such as topical formulations.

Main Methods:

• Review of existing literature, including case reports and uncontrolled studies on PFS.
• Critical analysis of studies reporting persistent side effects.
• Expert commentary on the management of finasteride-related concerns.

Main Results:

• Low-quality studies with bias and nocebo effects dominate the literature on PFS.
• The scientific community has not validated PFS as a distinct nosologic entity.
• Evidence does not confirm or refute PFS, making it inappropriate to dismiss or demonize finasteride.

Conclusions:

• Effective management of hair loss and addressing patient distress are paramount, regardless of PFS etiology.
• Practical guidance is needed for patient selection, risk assessment, information, and managing adverse events.
• Topical finasteride is presented as a potential alternative for managing male pattern hair loss with reduced systemic exposure.